GO:0005942 phosphatidylinositol 3-kinase complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005942 defines the phosphatidylinositol 3-kinase complex, a protein assembly with PI3K catalytic activity, divided into classes I, II, and III based on subunit composition.
• Class I PI3K complexes are obligate heterodimers of a catalytic subunit (e.g., PIK3CA) and a regulatory subunit (e.g., PIK3R1) and are central to growth factor signaling.
• Class III PI3K complexes, such as the PIK3C3-PIK3R4 complex, are essential for autophagy and vesicular trafficking.
• Dysregulation of PI3K complexes drives cancer, including gastric and prostate cancers, through constitutive activation of AKT-mTOR signaling.
• Noncanonical PI3Kγ signaling in leukemia highlights targetable dependencies beyond class I PI3Kα.
• CRISPR-based knockout, knock-in, and point mutation models are key to dissecting subunit-specific functions of PI3K complexes.
Description
The phosphatidylinositol 3-kinase complex (GO:0005942) is a cellular component defined by its ability to catalyze the phosphorylation of phosphatidylinositol lipids, a critical step in signal transduction. This complex is not a single entity but a family of assemblies classified into three classes (I, II, and III) that differ in subunit composition, taxonomic distribution, and regulatory mechanisms. Class I complexes are heterodimers of catalytic and regulatory subunits, class II complexes contain adaptor proteins, and class III complexes include regulatory subunits such as PIK3R4. Researchers study this complex because it sits at the nexus of growth factor signaling, autophagy, and immune regulation, with direct implications for cancer, infectious diseases, and metabolic disorders.
phosphatidylinositol 3-kinase complex At A Glance
| GO ID | GO:0005942 |
|---|---|
| GO term | phosphatidylinositol 3-kinase complex |
| Ontology | cellular_component |
| Synonym | PI3K complex; 1-phosphatidylinositol 3-kinase complex; phosphoinositide 3-kinase complex; PIK3CA-PIK3R1 complex; PIK3C3-PIK3R4 complex |
| Major function | Catalyzes phosphorylation of phosphatidylinositol lipids to generate signaling molecules such as PIP3 |
| Classes | Class I, II, and III, distinguished by subunit composition and taxonomy |
| Catalytic subunits | Present in all classes (e.g., PIK3CA, PIK3CB, PIK3CD, PIK3C3) |
| Regulatory subunits | Present in classes I and III (e.g., PIK3R1, PIK3R4) |
| Adaptor proteins | Observed in class II complexes and possibly other classes |
What Is GO:0005942?
According to the Gene Ontology, GO:0005942 describes a protein complex capable of phosphatidylinositol 3-kinase activity and containing subunits of any PI3K enzyme. These complexes are divided into three classes (I, II, and III) that differ in their presence across taxonomic groups and in the type of their constituents. Catalytic subunits are present in all three classes; regulatory subunits are present in classes I and III; adaptor proteins have been observed in class II complexes and may be present in other classes.
Why Is phosphatidylinositol 3-kinase complex Important in Cell Biology?
The phosphatidylinositol 3-kinase complex is a central hub in cellular signaling, controlling processes from cell growth and survival to autophagy and immune responses. Its dysregulation is implicated in a wide range of human diseases, including gastric cancer, prostate cancer, leukemia, and infections by intracellular bacteria such as Rickettsia typhi. Understanding its structure, assembly, and regulation is therefore critical for developing targeted therapies and for interpreting genomic data in cancer research.
• Central to growth factor signaling through generation of PIP3 and activation of AKT-mTOR pathways.
• Class III PI3K complexes are essential for autophagy and lysosomal trafficking.
• Mutations in PIK3CA and PIK3R1 are frequent in human cancers, including gastric and prostate cancers.
• Noncanonical PI3Kγ signaling represents a targetable dependency in leukemia.
• PI3K effectors are exploited by intracellular pathogens like Rickettsia typhi for survival.
• Computational design of PI3K inhibitors relies on detailed structural knowledge of the complex.
• The complex is a key node in crosstalk between AKT, MAPK, and WNT signaling pathways.
• Traditional medicine studies investigate PI3K pathway modulation in chronic atrophic gastritis.
• PI3K-related kinases share architectural features with PI3K complexes, informing drug design.
What Happens During phosphatidylinositol 3-kinase complex?
Activation by Receptor Tyrosine Kinases
In simple terms: Growth factors bind to receptors on the cell surface, which then recruit and activate PI3K complexes.
Class I PI3K complexes are activated downstream of receptor tyrosine kinases (RTKs) or G-protein coupled receptors. The regulatory subunit (e.g., PIK3R1) binds to phosphorylated tyrosine residues on activated receptors or adaptor proteins, relieving inhibition of the catalytic subunit (e.g., PIK3CA) and allowing it to phosphorylate phosphatidylinositol 4,5-bisphosphate (PIP2) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). This lipid second messenger recruits AKT and other signaling proteins to the membrane, propagating growth and survival signals.
Autophagy Initiation by Class III Complexes
In simple terms: Class III PI3K complexes help cells recycle components by starting the autophagy process.
The class III PI3K complex, containing PIK3C3 (Vps34) and regulatory subunits like PIK3R4 (Vps15) and NRBF2/Atg38, is essential for autophagosome formation. It generates phosphatidylinositol 3-phosphate (PI3P) at the phagophore assembly site, recruiting downstream effectors that drive membrane elongation and cargo sequestration. This process is critical for cellular homeostasis and response to stress.
Signal Propagation to AKT and mTOR
In simple terms: The lipid products of PI3K recruit proteins that trigger cell growth and survival.
PIP3 generated by class I PI3K complexes serves as a docking site for pleckstrin homology (PH) domain-containing proteins such as AKT and PDK1. AKT activation leads to phosphorylation of numerous downstream targets, including mTOR, which promotes protein synthesis and cell cycle progression. This pathway is frequently hyperactivated in cancer due to mutations in PI3K subunits or loss of PTEN.
Pathogen Exploitation of PI3K Signaling
In simple terms: Some bacteria hijack PI3K complexes to survive inside host cells.
Intracellular pathogens like Rickettsia typhi express effectors such as Risk1, a phosphatidylinositol 3-kinase effector that promotes bacterial survival by modulating host PI3K signaling. This highlights the complex's role beyond normal physiology in infectious disease.
Key Genes Involved in GO:0005942 phosphatidylinositol 3-kinase complex
The following genes encode subunits and regulators of the phosphatidylinositol 3-kinase complex, each with distinct roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIK3CA | Catalytic subunit of class I PI3K (p110α) | Frequently mutated in cancers; target for inhibitors |
| PIK3CB | Catalytic subunit of class I PI3K (p110β) | Implicated in PTEN-deficient tumors |
| PIK3CD | Catalytic subunit of class I PI3K (p110δ) | Role in immune cell signaling and leukemia |
| PIK3CG | Catalytic subunit of class I PI3K (p110γ) | Noncanonical signaling in leukemia |
| PIK3C2A | Catalytic subunit of class II PI3K | Less studied; potential role in vesicle trafficking |
| PIK3C3 | Catalytic subunit of class III PI3K (Vps34) | Essential for autophagy; target in cancer and neurodegeneration |
| PIK3R1 | Regulatory subunit of class I PI3K (p85α) | Mutations in cancer and immune disorders |
| PIK3R2 | Regulatory subunit of class I PI3K (p85β) | Modulates PI3K signaling in development |
| PIK3R3 | Regulatory subunit of class I PI3K (p55γ) | Tissue-specific regulatory roles |
| PIK3R4 | Regulatory subunit of class III PI3K (Vps15) | Required for autophagy and endosomal trafficking |
| NRBF2 | Subunit of class III PI3K complex I (Atg38) | Regulates autophagy and has links to disease |
| AKT1 | Downstream effector of PI3K signaling | Central to survival signaling; drug target |
| MTOR | Kinase activated by PI3K/AKT pathway | Integrates growth signals; target of rapamycin |
| PTEN | Lipid phosphatase that opposes PI3K | Tumor suppressor frequently lost in cancers |
| RPTOR | Component of mTORC1 downstream of PI3K | Regulates protein synthesis |
| RICTOR | Component of mTORC2 downstream of PI3K | Regulates AKT activation |
| RPS6KB1 | Downstream effector of mTOR | Readout of PI3K pathway activity |
How Is phosphatidylinositol 3-kinase complex Regulated?
The phosphatidylinositol 3-kinase complex is tightly regulated by multiple mechanisms. Class I PI3K activity is controlled by RTK-mediated recruitment and by the lipid phosphatase PTEN, which dephosphorylates PIP3 to terminate signaling. Class III PI3K is regulated by nutrient status and autophagy-related proteins such as NRBF2/Atg38, which modulates complex assembly and activity. Additionally, PI3K-related kinases share structural features that inform regulatory mechanisms. Dysregulation of these control points is common in cancer and other diseases.
phosphatidylinositol 3-kinase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIK3CA | Gastric cancer, prostate cancer, breast cancer | Knockout or point-mutation cell lines (e.g., HGC-27, PC-3) |
| PIK3R1 | Cancer, immune dysregulation | Knock-in of patient mutations in HEK293 or immune cells |
| PIK3C3 | Autophagy-related disorders, neurodegeneration | Knockout in neuronal cell lines or primary neurons |
| NRBF2 | Autophagy dysfunction, disease risk | Knockout and rescue with tagged knock-in |
| PIK3CG | Leukemia | Knockout in leukemia cell lines and xenografts |
PI3K Complex in Cancer
Mutations in PIK3CA and PIK3R1 are among the most frequent oncogenic alterations in human cancers, leading to constitutive activation of PI3K signaling and downstream AKT-mTOR pathways. In gastric cancer, targeting PI3K/AKT/mTOR and MAPK pathways is a major therapeutic strategy. Prostate cancer also exhibits frequent PI3K pathway dysregulation, often in crosstalk with AR, MAPK, and WNT signaling. Noncanonical PI3Kγ signaling has been identified as a targetable dependency in leukemia.
PI3K Complex in Infectious Disease
Intracellular pathogens such as Rickettsia typhi exploit host PI3K complexes to promote their survival. The bacterial effector Risk1 functions as a phosphatidylinositol 3-kinase effector, highlighting a role for PI3K signaling in infection.
PI3K Complex in Autophagy-Related Disorders
Class III PI3K complexes are essential for autophagy, and their dysfunction is linked to neurodegenerative diseases and metabolic disorders. NRBF2/Atg38, a subunit of class III PI3K complex I, has been implicated in health and disease through its role in autophagy regulation.
Therapeutic Targeting of PI3K Complexes
Computational design of PI3K inhibitors is an active area, leveraging structural insights into the complex to develop selective drugs. Traditional medicine approaches, such as Jiawei Huangqi Guizhi decoction, are also being studied for their effects on PI3K/AKT/mTOR signaling in chronic atrophic gastritis.
From phosphatidylinositol 3-kinase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PIK3CA reduce tumor growth? | PIK3CA knockout cancer cell lines and xenografts |
| How do cancer-associated PIK3CA mutations affect signaling? | Point-mutation knock-in of hot-spot mutations (e.g., H1047R) |
| What is the role of NRBF2 in autophagy? | NRBF2 knockout and tagged knock-in for localization studies |
| Can PI3Kγ be targeted in leukemia? | PIK3CG knockout or overexpression in leukemia models |
| How does Risk1 modulate host PI3K? | Overexpression of Risk1 in host cells and infection models |
| What is the effect of PI3K inhibitors on signaling? | Overexpression of wild-type or mutant PI3K subunits followed by drug treatment |
How to Study the phosphatidylinositol 3-kinase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and drug sensitivity | Identifying synthetic lethal partners of PI3K mutations |
| Lipid kinase assay | PI3K catalytic activity | Testing inhibitors and mutants |
| Immunoprecipitation-mass spectrometry | Subunit composition | Defining class-specific complexes |
| Cryo-EM | 3D structure of PI3K complexes | Understanding activation and drug binding |
| Western blot for pAKT | Downstream pathway activation | Measuring PI3K signaling in cells |
| GFP-LC3 puncta assay | Autophagy induction | Studying class III PI3K function |
| Computational docking | Inhibitor binding prediction | Designing novel PI3K inhibitors |
| qPCR for PI3K subunits | Gene expression levels | Validating knockout or overexpression |
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to PI3K inhibitors or that are synthetic lethal with PI3K complex mutations. Such screens have been used to uncover dependencies in leukemia and solid tumors.
Biochemical Assays for PI3K Activity
In vitro kinase assays using recombinant PI3K complexes or immunoprecipitates measure the conversion of PIP2 to PIP3, providing direct readout of catalytic activity. These assays are essential for testing inhibitors and characterizing mutants.
Proteomic and Structural Analysis
Affinity purification coupled with mass spectrometry can define subunit composition of PI3K complexes. Structural studies using cryo-EM or X-ray crystallography reveal architecture and activation mechanisms, as reviewed for PI3K-related kinases.
Autophagy Flux Assays
LC3 lipidation and GFP-LC3 puncta formation are used to assess autophagy induction downstream of class III PI3K complexes. These assays are critical for studying NRBF2 and PIK3C3 function.
How CRISPR Can Be Used to Study GO:0005942 phosphatidylinositol 3-kinase complex
Knockout
CRISPR knockout of PI3K complex subunits (e.g., PIK3CA, PIK3C3, NRBF2) is used to abolish complex function and assess effects on signaling, autophagy, and cell viability. Knockout cell lines are valuable for drug sensitivity studies and for validating on-target effects of inhibitors.
Point Mutation
Point mutations in PI3K genes, such as PIK3CA H1047R or E545K, are introduced via CRISPR knock-in to model cancer-associated mutations. These models help dissect constitutive activation and test allele-specific drugs.
Knock-in
Knock-in of tagged versions of PI3K subunits (e.g., GFP-PIK3C3) allows live-cell imaging and proteomic analysis of complex assembly and localization. Knock-in of patient-derived mutations can also model disease.
Overexpression
Overexpression of wild-type or mutant PI3K subunits using CRISPR activation or lentiviral vectors is used to study gain-of-function effects, pathway activation, and resistance to inhibitors.
How EDITGENE Supports phosphatidylinositol 3-kinase complex Research
Researchers studying phosphatidylinositol 3-kinase complex-related genes often need to determine whether a candidate gene is causally involved in a specific signaling or disease context. This requires precise genetic models that can isolate the contribution of individual subunits, mutations, or regulatory elements.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol 3-kinase complex research.
Frequently Asked Questions About phosphatidylinositol 3-kinase complex
What is the phosphatidylinositol 3-kinase complex?
It is a protein complex with PI3K catalytic activity, classified into classes I, II, and III based on subunit composition, and it plays key roles in signaling, autophagy, and disease.
What genes are involved in the phosphatidylinositol 3-kinase complex?
Key genes include PIK3CA, PIK3CB, PIK3CD, PIK3CG, PIK3C3, PIK3R1, PIK3R2, PIK3R3, PIK3R4, and NRBF2, among others.
What is the function of GO:0005942?
GO:0005942 describes a protein complex capable of phosphatidylinositol 3-kinase activity, containing catalytic and regulatory subunits that generate lipid second messengers.
How is the phosphatidylinositol 3-kinase complex regulated?
It is regulated by receptor recruitment, PTEN-mediated dephosphorylation, and autophagy-related proteins like NRBF2, with dysregulation common in cancer.
What diseases are associated with PI3K complex mutations?
Mutations in PI3K complex genes are linked to gastric cancer, prostate cancer, leukemia, and autophagy-related disorders.
What are the classes of phosphatidylinositol 3-kinase complexes?
Classes I, II, and III differ in subunit composition: class I has catalytic and regulatory subunits, class II has adaptors, and class III includes regulatory subunits like PIK3R4.
How can I study the phosphatidylinositol 3-kinase complex in the lab?
Common methods include CRISPR knockout, lipid kinase assays, immunoprecipitation-mass spectrometry, and autophagy flux assays.
What is the role of PIK3C3 in autophagy?
PIK3C3 (Vps34) is the catalytic subunit of class III PI3K, essential for generating PI3P to initiate autophagosome formation.
Are there targeted therapies for PI3K complex-driven cancers?
Yes, PI3K inhibitors are in clinical use or trials, and computational design is advancing selective inhibitors.
How does Rickettsia typhi exploit PI3K?
Rickettsia typhi expresses Risk1, a PI3K effector that promotes intracellular survival by modulating host PI3K signaling.
Conclusion
The phosphatidylinositol 3-kinase complex (GO:0005942) is a cornerstone of cellular signaling, with essential roles in growth, survival, autophagy, and host-pathogen interactions. Its dysfunction is implicated in major human diseases, making it a prime target for therapeutic intervention and research. Understanding its components, assembly, and regulation through CRISPR models and biochemical assays will continue to yield insights into disease mechanisms and drug development.
References
- 1. Ohashi Y. 2021. Class III phosphatidylinositol 3-kinase complex I subunit NRBF2/Atg38 - from cell and structural biology to health and disease.. Autophagy 17(12):3897-3907 PMID: 33459128
- 2. Luo Q et al.. 2024. Targetable leukaemia dependency on noncanonical PI3Kγ signalling.. Nature 630(8015):198-205 PMID: 38720074
- 3. Morgos DT et al.. 2024. Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.. Int J Mol Sci 25(3) PMID: 38339127
- 4. Shorning BY et al.. 2020. The PI3K-AKT-mTOR Pathway and Prostate Cancer: At the Crossroads of AR, MAPK, and WNT Signaling.. Int J Mol Sci 21(12) PMID: 32630372
- 5. Rani I et al.. 2022. Computational Design of Phosphatidylinositol 3-Kinase Inhibitors.. Assay Drug Dev Technol 20(7):317-337 PMID: 36269231
- 6. Voss OH et al.. 2020. Risk1, a Phosphatidylinositol 3-Kinase Effector, Promotes Rickettsia typhi Intracellular Survival.. mBio 11(3) PMID: 32546622
- 7. Xia Z et al.. 2025. Effect of Jiawei Huangqi Guizhi decoction on the expression of gastrin content and phosphatidylinositol 3-kinase/ protein kinase B/mechanistic target of rapamycin complex 2 signalling pathways in rats with chronic atrophic gastritis.. J Tradit Chin Med 45(4):770-776 PMID: 40810222
- 8. Imseng S et al.. 2018. Architecture and activation of phosphatidylinositol 3-kinase related kinases.. Curr Opin Struct Biol 49:177-189 PMID: 29625383
